XML 17 R7.htm IDEA: XBRL DOCUMENT v3.23.2
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Jul. 31, 2023
Jul. 31, 2022
Jul. 31, 2023
Jul. 31, 2022
Cash flows from operating activities:        
Net Income (Loss) $ 260 $ 1,238 $ 1,967 $ 6,802
Adjustments to reconcile net income to net cash provided by (used for) operating activities:        
Provision for doubtful accounts (33) 14 29 (179)
Deferred income taxes (68) (70) 233 (5)
Equity in (income) loss of affiliates (117) (72) (339) (462)
Foreign currency (gain) loss (144) 836 (2,387) 2,018
Unrealized (gain) loss on derivatives 272 152 322 (176)
Depreciation and amortization 1,037 1,049 3,141 2,956
Stock-based compensation 756 791 2,280 2,386
Change in assets and liabilities:        
(Increase) decrease in accounts receivable 1,518 (2,154) 7,472 4,408
(Increase) decrease in inventories (4,150) (9,518) (14,621) (22,194)
(Increase) decrease in prepaid expenses 206 256 (2,450) 5,638
Increase (decrease) in accounts payable (8,187) (814) (5,981) 2,937
Increase (decrease) in customer deposits (309) 220 404 (1,924)
Increase (decrease) in accrued expenses (227) 1,195 (2,154) 1,057
Increase (decrease) in accrued payroll and employee benefits 384 667 (2,420) (1,573)
Net change in deferred tax assets and liabilities (257) (67) (1,237) 813
Net change in derivative assets and liabilities 115 104 715 75
Other (203) 302 (1,156) (136)
Net cash provided by (used for) operating activities (9,147) (5,871) (16,182) 2,441
Cash flows from investing activities:        
Proceeds from sale of property and equipment   2 1 103
Purchase of property and equipment (154) (320) (811) (828)
Software development costs (191) (202) (940) (800)
Other investments     273  
Net cash provided by (used for) investing activities (345) (520) (1,477) (1,525)
Cash flows from financing activities:        
Proceeds from exercise of common stock options     270 117
Dividends paid (1,059) (1,004) (3,093) (2,927)
Taxes paid related to net settlement of restricted shares     (313) (208)
Stock repurchases     (4,609) (2,890)
Net cash provided by (used for) financing activities (1,059) (1,004) (7,745) (5,908)
Effect of exchange rate changes on cash and cash equivalents (574) (1,111) 2,512 (5,535)
Net increase (decrease) in cash and cash equivalents (11,125) (8,506) (22,892) (10,527)
Cash and cash equivalents at beginning of period 52,155 82,042 63,922 84,063
Cash and cash equivalents at end of period 41,030 $ 73,536 41,030 $ 73,536
Cash and cash equivalents at beginning of period     63,922  
Cash and cash equivalents at end of period $ 41,030   $ 41,030